Status: Recruiting
Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity
Patients with biochemically confirmed primary hyperparathyroidism and non-localizing SPECT-CT exam within the past year will be included. Subjects will be treated with calcitonin to lower calcium levels immediately prior to reimaging. The goal of this study is to determine whether lowering calcium will improve uptake/retention of sestamibi and improve sensitivity of SPECT-CT to localize parathyroid adenoma.
Participants needed: 37
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Joseph SferraUpdated: Sep 19, 2024Locations: 1
Eligibility criteria
Diagnosis of primary hyperparathyroidism [+6]
Previous surgery to the neck, including resection of parathyroid tissue, except... [+13]